newsfilter
← Latest News
PR Newswire·

First patent issued in Europe for Orexo's adrenaline product OX640

UPPSALA, Sweden, Sept. 1, 2022 /PRNewswire/ -- Orexo AB (publ.), (STO: ORX) (OTCQX:ORXOY) today announces that the European Patent Office (EPO) has granted the first European patent specifically relating to OX640, Orexo's nasal adrenaline rescue medicat